Connection

EUGENIE S KLEINERMAN to NK Cell Lectin-Like Receptor Subfamily K

This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about NK Cell Lectin-Like Receptor Subfamily K.
  1. Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases. Cancer Immunol Res. 2017 04; 5(4):300-311.
    View in: PubMed
    Score: 0.141
  2. CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors. Mol Cancer. 2014 Feb 24; 13:34.
    View in: PubMed
    Score: 0.115
  3. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells. Pharm Res. 2015 Mar; 32(3):779-92.
    View in: PubMed
    Score: 0.112
  4. Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis. Pediatr Blood Cancer. 2014 Apr; 61(4):618-26.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.